S&P 500
(0.04%) 5 223.37 points
Dow Jones
(-0.02%) 39 425 points
Nasdaq
(0.26%) 16 430 points
Oil
(-1.67%) $77.80
Gas
(-1.60%) $2.34
Gold
(0.40%) $2 352.30
Silver
(0.56%) $28.60
Platinum
(3.10%) $1 042.10
USD/EUR
(-0.21%) $0.925
USD/NOK
(0.14%) $10.82
USD/GBP
(-0.22%) $0.795
USD/RUB
(-0.29%) $91.33

Realtime updates for Graphite Bio, Inc. [GRPH]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated21 Mar 2024 @ 16:00

-2.75% $ 3.18

Live Chart Being Loaded With Signals

Commentary (21 Mar 2024 @ 16:00):

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States...

Stats
Today's Volume 299 406
Average Volume 40 955.00
Market Cap 185.19M
EPS $-0.400 ( 2024-03-25 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.207
ATR14 $0.0600 (0.27%)
Insider Trading
Date Person Action Amount type
2023-07-28 Drapkin Kimberlee C Buy 40 000 Stock Option (right to buy)
2023-07-28 Drapkin Kimberlee C Buy 0
2023-07-19 Viney Joanne L. Buy 20 000 Stock Option (right to buy)
2023-07-19 Porteus Matthew Buy 20 000 Stock Option (right to buy)
2023-07-19 Karsen Perry A Buy 20 000 Stock Option (right to buy)
INSIDER POWER
100.00
Last 97 transactions
Buy: 36 276 632 | Sell: 68 481 989

Volume Correlation

Long: 0.15 (neutral)
Short: 0.77 (moderate)
Signal:(51.506) Neutral

Graphite Bio, Inc. Correlation

10 Most Positive Correlations
RAM0.943
FAAR0.941
MTEK0.936
PRIM0.936
IXAQ0.934
EVER0.934
GHRS0.933
JUPW0.933
NVAC0.931
SVFAU0.931
10 Most Negative Correlations
DYNT-0.95
FTFT-0.949
INFI-0.939
HCDIP-0.938
DGLY-0.935
HFFG-0.929
BMRC-0.928
CGRN-0.927
CMLS-0.927
APPS-0.926

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Graphite Bio, Inc. Correlation - Currency/Commodity

The country flag -0.47
( neutral )
The country flag -0.47
( neutral )
The country flag 0.00
( neutral )
The country flag -0.57
( weak negative )
The country flag 0.00
( neutral )
The country flag 0.30
( neutral )

Graphite Bio, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $-2.41M (0.00 %)
EPS: $-2.19
FY 2023
Revenue: $0
Gross Profit: $-2.41M (0.00 %)
EPS: $-2.19
FY 2022
Revenue: $0
Gross Profit: $-8.35M (0.00 %)
EPS: $-1.760
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-2.45

Financial Reports:

No articles found.

Graphite Bio, Inc.

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators